Usefulness of B-Type Natriuretic Peptide and Cardiac Troponin Levels to Predict In-Hospital Mortality from ADHERE
- 15 January 2008
- journal article
- research article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 101 (2), 231-237
- https://doi.org/10.1016/j.amjcard.2007.07.066
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary ArticleCirculation, 2005
- Minor myocardial damage detected by troponin T is a powerful predictor of long-term prognosis in patients with acute decompensated heart failureInternational Journal of Cardiology, 2005
- Clinical applications of B-type natriuretic peptide (BNP) testingEuropean Heart Journal, 2003
- Cardiac Troponin I Is Associated With Impaired Hemodynamics, Progressive Left Ventricular Dysfunction, and Increased Mortality Rates in Advanced Heart FailureCirculation, 2003
- Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failureThe American Journal of Cardiology, 2002
- Persistently Increased Serum Concentrations of Cardiac Troponin T in Patients With Idiopathic Dilated Cardiomyopathy Are Predictive of Adverse OutcomesCirculation, 2001
- Cardiac troponin I as diagnostic and prognostic marker in severe heart failureThe Journal of Heart and Lung Transplantation, 2000
- Cardiac troponins in congestive heart failureAmerican Heart Journal, 1999
- Natriuretic PeptidesThe New England Journal of Medicine, 1998
- Circulating Cardiac Troponin I in Severe Congestive Heart FailureCirculation, 1997